[VRDN] QoQ Quarter Result on 31-Dec-2020 [#Q4]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
26-Mar-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- -1,551.66%
YoY- -796.84%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 208 1,090 1,451 54 0 168 828 -60.15%
PBT -14,043 -17,964 -18,460 -90,742 -5,494 -6,435 -8,044 44.93%
Tax 91 9 55 130 -48 33 27 124.62%
NP -14,043 -17,964 -18,460 -90,742 -5,494 -6,435 -8,044 44.93%
Tax Rate - - - - - - - -
Total Cost 14,251 19,054 19,911 90,796 5,494 6,603 8,872 37.11%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin -6,751.44 -1,648.07 -1,272.23 -168,040.74 0.00 -3,830.36 -971.50 263.73%
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
EPS -1.26 -2.22 -2.91 -23.07 -1.48 -1.82 -2.65 -39.05%
EPS Diluted -1.26 -2.22 -2.91 -23.07 -1.48 -1.82 -2.65 -39.05%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.